Podcasts for Health Professionals
- Wolff Award Paper 2015 – Accurate Classification of Chronic Migraine via Brain Magnetic Resonance Imaging
- pH-Evoked Dural Afferent Signaling is Mediated by ASIC3 and is Sensitized by Mast Cell Mediators
- Prescription Headache Medication in OEF/OIF Veterans: Results from the Women Veterans Cohort Study
- Sports Concussion and Associated Post-Traumatic Headache
- Panic Disorder and Migraine: Comorbidity, Mechanisms, and Clinical Applications
- The Portrayal of Migraine in Popular Music: Observations and Implications
- Self-Reported Comorbid Pains in Severe Headaches or Migraines in a US National Sample
- The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison with Other Recent Clinical practice Guidelines
- Adverse Chidhood Experiences are Associated with Migraine and Vascular Biomarkers
- Chronic Daily Headache in U.S. Soldiers After Concussion
- Concomitant Use of Triptan, and SSRI or SNRI After the Food and Drug Administration Alert on Serotonin Syndrome
- Headache Among Patients With HIV Disease: Prevalance, Characteristics, and Associations
- Rescue Therapy for Acute Migraine, Part 2: Neuroleptics, Antihistamines, and Others
- The Point Prevalence of Dizziness or Vertigo in Migraine - and Factors That Influence Presentation
- Tolerance to the Beneficial Effects of Prophylactic Migraine Drugs: A Systematic Review of Causes and Mechanisms
- Sex-Related Differences in Epidemiological and Clinic-Based Headache Studies
- Abdominal Migraine: An Under-Diagnosed Cause of Recurrent Abdominal Pain in Children
- MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine
- Preventive Medication Adherence in African American and Caucasian Headache Patients
- Alternative Headache Treatments: Nutraceuticals, Behavioral and Physical Treatments
- Cluster Headache - Acute and Prophylactic Therapy
- Commentary from the Refractory Headache Special Interest Section on Defining the Pharmacologically Intractable Headache for Clinical Trials and Clinical Practice
- A Comparison of OnabotulinumtoxinA and Topiramate for the Treatment of Chronic Migraine
- What's New in Headache - Fall 2010
- The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper
- Migraine and Obesity: Epidemiology, Mechanisms, and Implications
- Child Maltreatment and Migraine (Parts I, II, and III)
Wolff Award Paper 2015 – Accurate Classification of Chronic Migraine via Brain Magnetic Resonance Imaging
In this study, multivariable models of brain cortical surface area, cortical thickness, and regional volumes were accurate for identifying the MRIs of individuals with chronic migraine. These classifiers differentiated the MRIs of individual patients with chronic migraine from those of healthy controls with 86.3% accuracy and from those of patients who have episodic migraine with 84.2% accuracy. Listen to Dr. Schwedt's podcast interview. Listen to Dr. Schwedt's podcast interview.
Dr. Gregory Dussor of the University of Arizona reports the pathophysiology that underlies migraine headache is poorly understood. His study focuses on mechanisms contributing to the headache phase of migraine that probably requires afferent nociceptive signaling from the cranial meninges.
Dr. Elizabeth Seng of the VA Connecticut Healthcare System examines taking prescription headache medication among male and female Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) veterans.
In this podcast, Dr. Tad Seifert discussed Sports Concussion and Associated Post-Traumatic Headache. Dr. Seifert is the Director of the sports concussion program at Norton Neuroscience Institute in Louisville, KY. He is also an assistant professor of neurology at the University of Kentucky.
Panic Disorder and Migraine: Comorbidity, Mechanisms, and Clinical Applications
In this podcast, Jason Roberts of the Headache editorial office interviews Dr. Todd Smitherman, author of the paper: Panic Disorder and Migraine: Comorbidity, Mechanisms, and Clinical Applications.
Drs. Daniel Roberts and Bert Vargas discuss their article on The Portrayal of Migraine in Popular Music: Observations and Implications.
Daniel Roberts, MD, is an Assistant Professor of Medicine at Mayo Medical School. He is a hospitalist at Mayo Clinic in Phoenix, AZ.
Bert Vargas, MD, is an Assistant Professor of Neurology at the Mayo Clinic in Arizona.
Dr. Wayne Anderson discusses the paper with Dr. Octavia Plesh.
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison with Other Recent Clinical Practice Guidelines
Dr. Elizabeth Loder is the Chief of the Division of Headache and Pain in the Department of Neurology at the Brigham and Women's/Faulkner Hospital in Boston, MA. Dr. Loder is also President of the American Headache Society from 2012 - 2014.
Dr. Gretchen Tietjen, a graduate of the University of Michican Medical School, is a Professor and Chair of Neurology at the University of Toledo. She specializes in Vascular Neurology and Headache Medicine. Dr. Tietjen researches the relationship of migraine and stroke, and also on the long-term health effects of childhood abuse.
Chronic Daily Headache in U.S. Soldiers After Concussion
Major Brett J. Theeler is an active duty neurologist in the United States Army Medical Corps. He is currently stationed at Fort Sam Houston, Texas in the AMEDD Student Detachment, 187th Medical Battalion.
Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome
In this podcast, Jason Roberts of the Headache editorial office interviews Dr. David Sclar, author of the paper: Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome.
In this podcast, Jason Roberts of the Headache editorial office interviews Dr. Todd Smitherman, author of the paper: Headache Among Patients With HIV Disease: Prevalence, Characteristics, and Associations
In this podcast, Jason Roberts of the Headache editorial office interviews Dr. Deborah Tepper author of the paper: Rescue Therapy for Acute Migraine, Part 2: Neuroleptics, Antihistamines, and Others.
In this podcast, Dr. Wayne Anderson interviews Dr. Anne Calhoun of the Carolina Headache Institute, author of the paper The Point Prevalence of Dizziness or Vertigo in Migraine – and Factors That Influence Presentation.
Tolerance to the Beneficial Effects of Prophylactic Migraine Drugs: A Systematic Review of Causes and Mechamisms
In this podcast, Dr. Todd Schwedt interviews Dr. Paul Rizzoli, author of the paper Tolerance to the Beneficial Effects of Prophylactic Migraine Drugs: A Systematic Review of Causes and Mechanisms. Dr. Rizzoli is a Clinical Instructor in Neurology at Harvard Medical School and the Director of the Graham Headache Center. He is also the Director of the Headache Fellowship Program.
Anne MacGregor is Clinical Research Director at the City of London Migraine Clinic, an independent medical charity, and Honorary Professor at the Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry. Her research covers all aspects of headache and migraine with a particular interest in the effects of sex hormones on headache.
Dr. Donald Lewis was a pediatric neurologist at the Children’s Hospital of The King’s Daughters since 1993 and had served as Chairman of the Department of Pediatrics at Eastern Virginia Medical School since 2005.
Dr. Lewis is fundamentally a clinician-educator with research interests in headache and migraine in children and adolescents. He is the lead author for the two American Academy of Neurology Practice Parameter regarding the evaluation of children with recurrent headache and the management of pediatric migraine and co-author of three clinical monographs regarding headache in children, adolescents and young adults.
Sheena K. Aurora, MD, is a board certified neurologist and a headache specialist. She is the director of the Swedish Headache Center at the Swedish Pain and Headache Center in Seattle, Washington. Dr. Aurora was also one of the principal investigators of the first migraine program project funded by the National Institutes of Health. She is a board member of the American Headache Society, and serves on the editorial board. She has served on the headache section of the Academy of Neurology, is a member of the International Headache Society, and has contributed to more than 30 peer-reviewed publications.
Dr. Christina Sun-Edelstein is a Board-Certified Neurologist with subspecialty training and experience in both Headache and Epilepsy. After graduating from SUNY Brooklyn College of Medicine with honors, she completed her neurology residency at Mount Sinai Medical Center in New York. She subsequently spent a year as an Epilepsy Fellow at St. Vincent's Hospital Melbourne, and then returned to New York for her fellowship training in Headache Medicine at Roosevelt Hospital's Headache Institute. She worked at the NY Headache Center for several years before relocating to Australia in 2009. She is currently a headache specialist at St Vincent’s Hospital Melbourne.
Dr. Sun-Edelstein's awards and honors include the American Academy of Neurology's Resident Scholarship Award, the David Coddon Memorial Award (given by the Headache Cooperative of New England), the American Headache Society's Clinical Fellowship Award, and the American Headache Society's Travel Award. She has also been published in academic journals such as Archives of Neurology, Cephalalgia, and Headache, and has written several headache topics for the online medical reference UptoDate. Dr Sun-Edelstein also serves as a reviewer for peer-reviewed academic journals.
Avi Ashkenazi, MD, is currently a member of the Neurologic Group of Bucks/Montgomery County in Pennsylvania. Dr. Ashkenazi graduated from the Hadassah-Hebrew University Medical School in Jerusalem, Israel, where he also completed his Neurology residency. He completed a clinical fellowship in Headache and Facial Pain at Dartmouth-Hitchcock Medical Center in Lebanon, NH, and then continued his training as a Research Fellow in Headache and Facial Pain at Thomas Jefferson University Hospital. Dr. Ashkenazi then held a position as assistant professor of Neurology at Thomas Jefferson University and as attending physician at the Department of Neurology-Thomas Jefferson University Hospital.
Dr. Ashkenazi has published numerous papers and several book chapters on the clinical aspects and basic mechanisms of migraine and other headaches. His special interests include the use of peripheral nerve blocks and botulinum toxin injections for headaches; the mechanisms of phonophobia in migraine; cutaneous allodynia in migraine and other headaches; and hormone-related headaches. He recently directed a course on peripheral nerve blocks and other invasive procedures for headaches and facial pain at the American Academy of Neurology Annual Scientific Meeting in Toronto. Dr. Ashkenazi is an active member of the American Headache Society Special Interest Section on Peripheral Nerve Blocks and Other Interventional Procedures for Headache and Facial Pain. Dr. Ashkenazi is the recipient of the American Academy of Neurology Harold Wolff - John Graham Award for Headache and Facial Pain Research.
Commentary from the Refractory Headache Special Interest Section on Defining the Pharmacologically Intractable Headache for Clinical Trials and Clinical Practice
Elliott A. Schulman, MD, FAHS is a Board Certified Neurologist at Lankenau Hospital in Wynnewood, PA. He is also an Adjunct Clinical Professor of Neurology at Jefferson School of Medicine in Philadelphia, PA. Dr. Schulman is certified by the American Board of Psychiatry & Neurology and received UCNS Headache Medicine Certification. He is a Fellow of the American Headache Society® and American Academy of Neurology.
Dr. Schulman has published many journal articles in Headache, Neurology, Archives of General Psychology, Archives of Neurology, Clinical Pharmacology and Therapeutics, and Epilepsia. His current interests are refractory migraine headache and the role of abuse in headache and other pain states.
Roger K. Cady, MD, FAHS, is Director of the Headache Care Center, Director of Clinvest and Founder of Primary Care Network, as well as CEO of Banyan Group Inc., all located in Springfield, Missouri. Dr. Cady received his MD degree from the Mayo Medical School in Rochester, MN. He completed his residency in family practice at St. Francis Mayo in LaCrosse, WI, and is certified by the American Board of Family Practice. He is a fellow of the American Headache Society and a member of the American Medical Association, the American Academy of Pain Management and the American Academy of Family Physicians. Dr. Cady is associate executive chairman for the National Headache Foundation.
Dr. Cady was the co-recipient of the Harold Wolff Award in 2000 for his research on the spectrum of primary headache in migraine sufferers. In October 2009 he received the Janet Travell Pain Management Award which is presented to a clinician who has contributed to the advancement of the field of pain management and the welfare of others through direct clinical services.
He has been instrumental in developing the early intervention paradigm for treatment of acute migraine and defining “sinus headache” as a common clinical presentation of migraine. He has authored/co-authored over 150 peer-reviewed journal articles and has written and contributed to numerous books, chapters and abstracts as well as countless lectures and seminars around the world on headache, migraine and other chronic disorders. He has been and continues to be the principal investigator in multi-center studies on migraine, post-traumatic headache and other pain disorders.
Todd Schwedt, MD, Online Editor, Headache
-Botulinum toxin receives FDA approval for the treatment of chronic migraine
-Upcoming AHS events
The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper
Randolph W. Evans, MD, FAHS, a graduate of Baylor College of Medicine, is Clinical Professor of Neurology at Baylor College of Medicine in Houston, Texas and is subspecialty certified in Headache Medicine. He is on the editoral board of 11 journals including Headache and Headache Currents. Dr. Evans has published over 200 journal publications, 70 book chapters, and is the editor or co-author of 16 books.
Dr. Peterlin, a graduate of the Philadelphia College of Oseopathic Medicine, is the Director of Johns Hopkins Headache Research where she is an Assistant Professor in the Department of Neurology at Johns Hopkins Bayview. In addition to migraine and obesity, she has done research on the associations between migraine and both PTSD and physical and sexual abuse.
Dr. Gretchen Tietjen, a graduate of the University of Michigan Medical School, is a Professor and Chair of Neurology at the University of Toledo. She specializes in Vascular Neurology and Headache Medicine. She does research on the relationship of migraine and stroke, and also on the longterm health effects of childhood abuse.
- Current Issue
- Past Issues
- Early View
- Virtual Issues
- Most Cited Articles
- Most Viewed Articles
- Award Winning Articles
- Headache Extras
- Headache Guidelines
- Events Calender
Sales and Services